At the time of writing, Traws Pharma Inc [TRAW] stock is trading at $12.57, up 150.40%. An important factor to consider is whether the stock is rising or falling in short-term value. The TRAW shares have gain 167.58% over the last week, with a monthly amount glided 178.71%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Traws Pharma Inc [NASDAQ: TRAW] stock has seen the most recent analyst activity on March 01, 2022, when Ladenburg Thalmann initiated its Buy rating and assigned the stock a price target of $7. Previously, Guggenheim started tracking the stock with Buy rating on May 18, 2021, and set its price target to $4. On March 01, 2018, H.C. Wainwright reiterated its Buy rating and revised its price target to $7.50 on the stock. Maxim Group downgraded its rating to a Hold. H.C. Wainwright initiated its recommendation with a Buy and recommended $6 as its price target on October 09, 2017. Laidlaw started tracking with a Buy rating for this stock on April 27, 2017, and assigned it a price target of $10. In a note dated July 01, 2015, Piper Jaffray upgraded an Overweight rating on this stock.
For the past year, the stock price of Traws Pharma Inc fluctuated between $4.06 and $19.94. Traws Pharma Inc [NASDAQ: TRAW] shares were valued at $12.57 at the most recent close of the market.
Analyzing the TRAW fundamentals
Gross Profit Margin for this corporation currently stands at 0.95% with Operating Profit Margin at -106.61%, Pretax Profit Margin comes in at -622.94%, and Net Profit Margin reading is -622.94%. To continue investigating profitability, this company’s Return on Assets is posted at -15.75, Equity is 6.2 and Total Capital is -40.98.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.31 points at the first support level, and at 6.04 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.64, and for the 2nd resistance point, it is at 22.70.
Ratios To Look Out For
It is important to note that Traws Pharma Inc [NASDAQ:TRAW] has a current ratio of 1.07. On the other hand, the Quick Ratio is 1.07, and the Cash Ratio is 0.65. Considering the valuation of this stock, the price to sales ratio is 155.62.
